---
title: "Clonidine - Attention deficit hyperactivity disorder"
sidebar: mydoc_sidebar
permalink: db00575-mesh-d001289-1.html
toc: false 
---


Path ID: `DB00575_MESH_D001289_1`
{% include image.html url="images/db00575-mesh-d001289-1.png" file="db00575-mesh-d001289-1.png" alt="db00575-mesh-d001289-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D003000 | Clonidine | Drug |
| UniProt:P08913 | Alpha-2A adrenergic receptor | Protein |
| UBERON:0000451 | prefrontal cortex | GrossAnatomicalStructure |
| GO:0048243 | secretion of norepinephrine | BiologicalProcess |
| HP:0007018 | irrelevant attention | PhenotypicFeature |
| MESH:D001289 | Attention deficit hyperactivity disorder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Clonidine | INCREASES ACTIVITY OF | Alpha-2A Adrenergic Receptor |
| Alpha-2A Adrenergic Receptor | LOCATED IN | Prefrontal Cortex |
| Prefrontal Cortex | PREVENTS | Secretion Of Norepinephrine |
| Secretion Of Norepinephrine | DISRUPTS | Irrelevant Attention |
| Irrelevant Attention | CORRELATED WITH | Attention Deficit Hyperactivity Disorder |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00575#mechanism-of-action](https://go.drugbank.com/drugs/DB00575#mechanism-of-action){:target="_blank"}